SN(SN)
SN
Q4 2026 EPS Estimate
$1.89
Nov 5, 2026
Revenue Estimate
$1.86B
FY2026E EPS$6.36
FY2027E EPS$7.32
Analyst Sentiment
Wall St. Consensus
Buy11 analysts·Moderate coverage
73
Score
10 Buy (91%)1 Hold (9%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1091%
Hold
19%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$145.00
-21.5%
Consensus
$204.00
+10.4%
Bull
$219.10
+18.6%
12-Month Target Range11 analysts
$145.00$204.00$219.10
Current $184.79Consensus
Current Price
$184.79
Upside to Consensus
$19.21
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+12.03%
EPS+15.06%
FY2028
Rev+10.95%
EPS+13.01%
FY2029
Rev+7.82%
EPS+18.16%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $7.38B | $8.27B | $9.17B | $9.89B | $10.68B |
| Low | $7.37B | $8.20B | $8.80B | $9.68B | $10.46B |
| High | $7.66B | $8.38B | $9.71B | $10.27B | $11.09B |
| EBITDA Avg | $973M | $1.09B | $1.21B | $1.30B | $1.41B |
| Low | $972M | $1.08B | $1.16B | $1.28B | $1.38B |
| High | $1.01B | $1.11B | $1.28B | $1.35B | $1.46B |
| EBIT Avg | $807M | $904M | $1.00B | $1.08B | $1.17B |
| Low | $806M | $897M | $963M | $1.06B | $1.14B |
| High | $838M | $917M | $1.06B | $1.12B | $1.21B |
| Net Income Avg | $911M | $1.04B | $1.15B | $1.39B | $1.57B |
| Low | $895M | $999M | $1.14B | $1.35B | $1.53B |
| High | $928M | $1.07B | $1.21B | $1.46B | $1.65B |
| EPS Avg | $6.36 | $7.32 | $8.27 | $9.78 | $11.03 |
| Low | $6.30 | $7.03 | $8.04 | $9.52 | $10.74 |
| High | $6.53 | $7.50 | $8.51 | $10.27 | $11.58 |
| Analysts (Rev / EPS) | 9 / 6 | 10 / 8 | 6 / 2 | 4 / 1 | 3 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $1.85B | $2.41B | $1.59B | $1.94B | $2.08B | $2.68B |
| Low | $1.84B | $2.39B | $1.57B | $1.93B | $2.05B | $2.65B |
| High | $1.86B | $2.43B | $1.65B | $2.02B | $2.15B | $2.78B |
| EBITDA Avg | $244M | $318M | $210M | $257M | $274M | $353M |
| Low | $242M | $315M | $208M | $254M | $271M | $350M |
| High | $245M | $321M | $217M | $266M | $284M | $366M |
| EBIT Avg | $202M | $264M | $174M | $213M | $227M | $293M |
| Low | $201M | $262M | $172M | $211M | $225M | $290M |
| High | $203M | $266M | $180M | $220M | $235M | $304M |
| Net Income Avg | $258M | $325M | $180M | $206M | $285M | $379M |
| Low | $254M | $324M | $178M | $204M | $281M | $374M |
| High | $261M | $328M | $188M | $216M | $299M | $397M |
| EPS Avg | $1.82 | $2.30 | $1.27 | $1.46 | $2.01 | $2.68 |
| Low | $1.79 | $2.29 | $1.26 | $1.44 | $1.99 | $2.64 |
| High | $1.85 | $2.32 | $1.33 | $1.53 | $2.11 | $2.81 |
| Analysts (Rev / EPS) | 7 / 8 | 7 / 7 | 3 / 2 | 3 / 2 | 3 / 2 | 6 / 5 |